ACACIA

Acacia Research Reports First Quarter 2021 Financial Results

Retrieved on: 
Montag, Mai 17, 2021

Our focus remains the small-cap value sector with the goal of acquiring operating companies in the mature technology, healthcare, industrial and certain financial services segments.

Key Points: 
  • Our focus remains the small-cap value sector with the goal of acquiring operating companies in the mature technology, healthcare, industrial and certain financial services segments.
  • Maureen O\xe2\x80\x99Connell, Chairman of the Board of Acacia, and Isaac Kohlberg, a director of Acacia, were appointed to the Arix board as well.
  • This was driven by the increase in Acacia\xe2\x80\x99s share price from $3.94 at December 31, 2020 to $6.65 at March 31, 2021.
  • We undertake no obligation to revise or update publicly any forward-looking statements for any reason.\nThe results achieved in the most recent quarter are not necessarily indicative of the results to be achieved by us in any subsequent quarters, as it is currently anticipated that Acacia Research Corporation\xe2\x80\x99s financial results will vary, and may vary significantly, from quarter to quarter.

DGAP-News: ​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021

Retrieved on: 
Mittwoch, Mai 12, 2021

Jim Phillips, CEO of PAION AG, commented: "The first quarter of 2021 brought important progress in our transformation into a specialty pharma company.

Key Points: 
  • Jim Phillips, CEO of PAION AG, commented: "The first quarter of 2021 brought important progress in our transformation into a specialty pharma company.
  • We are now building our commercial organization and preparing launches for all three products in the second half of 2021, addressing important unmet medical needs.
  • PAION and Mundipharma have agreed on an amendment of the royalty calculation in the first quarter of 2021.
  • In the first quarter of 2021, the risks and opportunities have not changed significantly.\nPAION confirms its outlook for the current fiscal year given in March 2021 with the publication of the 2020 consolidated financial statements and group management report.

Acacia Research to Release First Quarter 2021 Financial Results

Retrieved on: 
Montag, Mai 10, 2021

b"Acacia Research Corporation (\xe2\x80\x9cAcacia\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d) (NASDAQ: ACTG) announced today it will release its first quarter 2021 financial results on Monday, May 17, 2021 at 8:00 a.m. ET/ 5:00 a.m. PT.\nThe Company will host a conference call on the same day to discuss these results at 11:00 a.m. ET/ 8:00 a.m. PT.\nTo access the live call, please dial (877) 407-0778 (U.S. and Canada) or (201) 689-8565 (international).

Key Points: 
  • b"Acacia Research Corporation (\xe2\x80\x9cAcacia\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d) (NASDAQ: ACTG) announced today it will release its first quarter 2021 financial results on Monday, May 17, 2021 at 8:00 a.m. ET/ 5:00 a.m. PT.\nThe Company will host a conference call on the same day to discuss these results at 11:00 a.m. ET/ 8:00 a.m. PT.\nTo access the live call, please dial (877) 407-0778 (U.S. and Canada) or (201) 689-8565 (international).
  • The conference call will also be simultaneously webcasted on the investor relations section of the Company\xe2\x80\x99s website at http://acaciaresearch.com under Events & Presentations.
  • These statements are based upon our current expectations and speak only as of the date hereof.
  • We undertake no obligation to revise or update publicly any forward-looking statements for any reason.\nThe results achieved in the most recent quarter are not necessarily indicative of the results to be achieved by us in any subsequent quarters, as it is currently anticipated that Acacia Research Corporation\xe2\x80\x99s financial results will vary, and may vary significantly, from quarter to quarter.

The Global Rolling Paper Leader Republic Brings Together Their OCB Brand and Wakit Grinders in Exclusive Partnership

Retrieved on: 
Dienstag, Mai 4, 2021

b'Republic, one of the world\xe2\x80\x99s largest and most prestigious brand portfolios of rolling papers and lifestyle accessories, announced today an exclusive wholesale distribution agreement with Wakit Grinders.

Key Points: 
  • b'Republic, one of the world\xe2\x80\x99s largest and most prestigious brand portfolios of rolling papers and lifestyle accessories, announced today an exclusive wholesale distribution agreement with Wakit Grinders.
  • Wakit is one of the most innovative brands in the category; that\xe2\x80\x99s why the partnership makes sense for us,\xe2\x80\x9d said Charlie Bachmann of OCB Rolling Papers .
  • That\xe2\x80\x99s why for the past 200 years OCB has been crafting unparalleled rolling papers using all-natural ingredients.
  • OCB is an industry leader in 100 countries and continues to deliver the best products to the world.

ADVA showcases 400ZR DCI solution with Acacia and Inphi

Retrieved on: 
Dienstag, April 13, 2021

The trial featured 400Gbit/s WDM transport using low-power 400ZR pluggable QSFP-DD transceivers from Acacia and Inphi with ADVA\xe2\x80\x99s FSP 3000 DCI OLS .

Key Points: 
  • The trial featured 400Gbit/s WDM transport using low-power 400ZR pluggable QSFP-DD transceivers from Acacia and Inphi with ADVA\xe2\x80\x99s FSP 3000 DCI OLS .
  • To validate three-way line-side interoperability, 400ZR was transmitted from Acacia to Inphi and vice versa.
  • View the full release here: https://www.businesswire.com/news/home/20210413005107/en/\nADVA\xe2\x80\x99s demo with Acacia and Inphi shows a clear route to open DCI networking with 400ZR technologies (Photo: Business Wire)\n\xe2\x80\x9cToday, we\xe2\x80\x99re showing a direct route to open DCI networking using 400ZR.
  • Designed to interoperate with all standards-based DWDM pluggable optics, the ADVA DCI OLS now features components specifically engineered to meet 400ZR DCI demands.

Naturally Functional Flax: Formulating Clean-Label Foods for Today's Consumer, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Donnerstag, April 8, 2021

It is vegan, non-allergenic, gluten free and non-GMO making it perfect for use in clean label product formulations.

Key Points: 
  • It is vegan, non-allergenic, gluten free and non-GMO making it perfect for use in clean label product formulations.
  • For more information, or to register for this event, visit Naturally Functional Flax: Formulating Clean-Label Foods for Today's Consumer.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)

Cisco Redesigns Internet Infrastructure to Support a More Inclusive Future

Retrieved on: 
Dienstag, März 30, 2021

Cisco continues to lead on creating the 'Internet for the Future' for the 5G era across silicon, routing and optical, network automation and more.

Key Points: 
  • Cisco continues to lead on creating the 'Internet for the Future' for the 5G era across silicon, routing and optical, network automation and more.
  • The internet went from being a must-have, to a critical lifeline for most everyone to connect to information, and each other.
  • Together with remote healthcare services, streaming video, gaming and more, internet traffic spiked by 25-45 percent in many regions across the globe1.
  • Cisco is introducing its new Cisco Cloud Native Broadband Network Gateway for telco customers (wireline), joining the Cisco family of existing cloud native broadband routers for cable and mobile.

Cosmo Full-Year Report 2020: Cosmo returns to operating profit

Retrieved on: 
Freitag, März 26, 2021

DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year results for the year ended 31 December 2020.

Key Points: 
  • DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year results for the year ended 31 December 2020.
  • In 2020, Cosmo received European approval for Methylene Blue MMX, received FDA approval for BYFAVO, continued to execute its equity for product strategy and has returned to operating profit.
  • Operating profit of 6.9 million compared to an operating loss of 12.3 million in 2019.
  • Cashflow inflow from operating activities of 10.1 million compared to a cash outflow from operating activities of 17.6 million in 2019.